Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-026287
Filing Date
2025-09-02
Accepted
2025-09-02 20:30:17
Documents
1
Period of Report
2025-08-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1516
  Complete submission text file 0001641172-25-026287.txt   2935
Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753
Business Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 718-673-6078
Curanex Pharmaceuticals Inc (Issuer) CIK: 0002025942 (see all company filings)

EIN.: 830741390 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753
Business Address
Yan Yong (Reporting) CIK: 0002084034 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42815 | Film No.: 251287476